/Investor DB

Declaration Partners — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Solidus Labssoliduslabs.comSeries B · May 2022 · $45M

Solidus Labs provides compliance and market monitoring software for cryptocurrency and traditional finance.

Crypto & Web3CybersecurityEnterprise SoftwareFintechNew York, US

Asaf Meir(Executive Officer, Director)inChen Arad(Director)inPraveen Kumar(Executive Officer, Director)Praveen K. Dosodia(Founder)

BoardProsor Lior(Director)Shimon Mazor(Director)

Co-investors645 VenturesBeacon VCEvolution Equity PartnersF-Prime CapitalHanaco Venture CapitalExor Seeds+3 more

Synthegosynthego.comin𝕏Feb 2022 · $200M

Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems.

BiotechDeep TechHealthtechMedical DevicesRedwood City, US

Paul John Dabrowski(Executive Officer, Director)Michael Jakub Dabrowski(Executive Officer, Director)Craig Christianson(CEO)inAlex Pesch(Founder)Michael Dabrowski(Founder)Paul Dabrowski(Founder)

Co-investorsAAF Management Ltd.AME Cloud VenturesFounders FundKhosla VenturesMenlo VenturesOpen Field Capital+11 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.